Experienced MedTech leader to scale manufacturing, drive European expansion, and position the company to enter the US market with the Kaleido insulin patch pump AID system
UTRECHT, The Netherlands, Feb. 26, 2025 /PRNewswire/ — ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest, and most precise insulin patch pump and automated insulin delivery (AID) system, today announced the appointment of Tom Arnold as Chief Executive Officer.
Tom brings almost 25 years of extensive leadership experience in diabetes and medical technology and has a strong track record in spearheading commercialization initiatives, business strategy, and product launches for leading medical device companies. He has held key leadership roles at Medtronic, PROCEPT BioRobotics, Boston Scientific, and Sorin Group. During his more than seven years at Medtronic, he played a pivotal role in launching the world’s first hybrid closed-loop insulin pump system by driving adoption through innovative commercialization strategies and payer access models.
Dieser Beitrag wurde original veröffentlicht auf: link zum Beitrag
